Cite
Karnezis AN, Leung S, Magrill J, et al. Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification. J Pathol Clin Res. 2017;3(4):279-293doi: 10.1002/cjp2.82.
Karnezis, A. N., Leung, S., Magrill, J., McConechy, M. K., Yang, W., Chow, C., Kobel, M., Lee, C. H., Huntsman, D. G., Talhouk, A., Kommoss, F., Gilks, C. B., & McAlpine, J. N. (2017). Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification. The journal of pathology. Clinical research, 3(4), 279-293. https://doi.org/10.1002/cjp2.82
Karnezis, Anthony N, et al. "Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification." The journal of pathology. Clinical research vol. 3,4 (2017): 279-293. doi: https://doi.org/10.1002/cjp2.82
Karnezis AN, Leung S, Magrill J, McConechy MK, Yang W, Chow C, Kobel M, Lee CH, Huntsman DG, Talhouk A, Kommoss F, Gilks CB, McAlpine JN. Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification. J Pathol Clin Res. 2017 Oct 14;3(4):279-293. doi: 10.1002/cjp2.82. eCollection 2017 Oct. PMID: 29085668; PMCID: PMC5653931.
Copy
Download .nbib